Increasing unusual put option volume: UNIT REN TSM LSI ALNY SSRM
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Alnylam Pharmaceuticals (ALNY) PT Raised to $134 at BMO Capital; Makes Case for $165 Upside Scenario
September 21, 2017 3:40 PM EDTBMO Capital analyst Do Kim raised his price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $134.00 (from $99.00) while maintaining an Outperform rating following strong APOLLO data.
"We believe an early restart of Fitusiran trials and positive Givosiran interim data (mid-2018) would enable shares to approach our $165 upside scenario," the analyst said.
... MoreAlnylam Pharmaceuticals (ALNY) PT Raised to $101 at Morgan Stanley
September 21, 2017 8:37 AM EDTMorgan Stanley raised its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $101.00 (from $50.00) while maintaining a Equalweight rating.
... MoreUPDATE: Alnylam Pharmaceuticals (ALNY) PT Raised to $146 at Ladenburg Thalmann
September 21, 2017 7:04 AM EDT(Updated - September 21, 2017 7:08 AM EDT)
(updated to add analyst comment)
Ladenburg Thalmann analyst Christopher James raised his price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $146.00 (from $90.00) while maintaining a Buy rating.
The analyst is positive on the results from... More
